Product Name:

NebuSelect™ Recombinant Human PILRA, hFc-tag

Catalog#:

NBL-242181

Description:

NebuSelect™ Recombinant Human PILRA, hFc-tag(Cat#NBL-242181) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Gln20-Ala197.

Species:

Human

Expression System:

HEK293

Molecular Weight: 

The protein has a predicted MW of 47 kDa. Due to glycosylation, the protein migrates to 60-68 kDa based on Bis-Tris PAGE result.

Target Name:

PILRA; PILRA; FDF03; PILRalpha; PILR-alpha

Target Information:

Alzheimer's disease (AD) is a neurodegenerative disease characterized by a progressive decline in cognitive performance; Mild Cognitive Impairment (MCI) is instead an objective decline in cognitive performance that does not reach pathology. Paired immunoglobulin-like type 2 receptor alpha (PILRA) is a cell surface inhibitory receptor that was recently suggested to be involved in AD pathogenesis. In particular, the arginine-to-glycine substitution in position 78 (R78, rs1859788) was shown to be protective against AD.

Amino Acid Sequence: 

Gln20-Ala197

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.